PMID: 9543198Jul 21, 1998Paper

Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics

Journal of Affective Disorders
M FryeR M Post

Abstract

Traditional neuroleptics are often utilized clinically for the management of bipolar disorder. Although effective as antimanic agents, their mood stabilizing properties are less clear. Additionally, their acute clinical side effect profile and long term risk of tardive dyskinesia, particularly in mood disorder patients, portend significant liability. This review focuses on the use of atypical antipsychotics in the treatment of bipolar disorder focusing on clozapine as the prototypical agent. Although, preclinical research and clinical experience suggest that the atypical antipsychotics are distinctly different from typical antipsychotics, they themselves are heterogeneous in profiles of neuropharmacology, clinical efficacy, and tolerability. The early clinical experience of clozapine as a potential mood stabilizer suggests greater antimanic than antidepressant properties. Conversely, very preliminary clinical experience with risperidone suggests greater antidepressant than antimanic properties and some liability for triggering or exacerbating mania. Olanzapine and sertindole are under investigation in psychotic mood disorders. The foregoing agents and future drugs with atypical neuroleptic properties should come to play an incr...Continue Reading

References

Sep 1, 1977·Comprehensive Psychiatry·R BattegayU Rauchfleisch
Dec 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·H M Van PraagL C Dols
Jan 11, 1992·Progress in Neuro-psychopharmacology & Biological Psychiatry·G GardosJ O Cole
Aug 1, 1992·Biological Psychiatry·T SuppesJ O Cole
Jan 1, 1992·Psychopharmacology·J O ColeP Moore
Mar 14, 1991·The New England Journal of Medicine·R J Baldessarini, F R Frankenburg
Dec 1, 1991·Journal of Clinical Psychopharmacology·J R CalabreseP J Markovitz
Jan 1, 1991·International Clinical Psychopharmacology·G EikmeierM Gastpar
Aug 15, 1991·The New England Journal of Medicine·L J FriedmanM Sved
Jan 1, 1991·Schizophrenia Bulletin·A SaffermanB Kinon
Sep 1, 1991·The American Journal of Psychiatry·G L FaeddaC Waternaux
Jul 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·R A O'ConnellB E O'Brien
Aug 1, 1990·Hospital & Community Psychiatry·D Naber, H Hippius
Feb 1, 1990·Journal of Clinical Psychopharmacology·G S SachsL Jones
Jun 1, 1990·Journal of Affective Disorders·M TohenA T Hunt
Nov 13, 1990·European Journal of Pharmacology·B GlenthøjT G Bolwig
Mar 1, 1990·The American Journal of Psychiatry·M J Wood, M Rubinstein
Jul 1, 1989·The American Journal of Psychiatry·R F Prien, A J Gelenberg
Jan 1, 1989·Psychopharmacology·M LeppigH Hippius
Apr 1, 1986·Archives of General Psychiatry·S MukherjeeS Shukla
Sep 1, 1988·Archives of General Psychiatry·S R Marder, T Van Putten
Nov 1, 1988·The American Journal of Psychiatry·H A NasrallahG A Hamdan-Allan
Feb 1, 1974·Archives of General Psychiatry·D L Dunner, R R Fieve
Jan 1, 1980·The American Journal of Psychiatry·G Chouinard, B D Jones
Mar 1, 1983·Archives of General Psychiatry·B J HamraR Finn
Dec 1, 1980·Journal of Affective Disorders·P E GarfinkelE Persad
Feb 1, 1981·Archives of General Psychiatry·T Van PuttenL A Wittmann
Sep 1, 1981·Acta Psychiatrica Scandinavica·U G AhlforsO Aaskoven
Nov 1, 1995·The American Journal of Psychiatry·M J GitlinC Hammen
Dec 1, 1995·Archives of General Psychiatry·J W Olney, N B Farber
Jan 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·K HeinrichH Hruschka
Jun 1, 1994·The American Journal of Psychiatry·S R Marder, R C Meibach
Oct 8, 1994·Lancet·A N Singh, J Catalan
Jan 1, 1993·Psychopharmacology·S SzymanskiT Cooper

❮ Previous
Next ❯

Citations

Nov 13, 2004·European Archives of Psychiatry and Clinical Neuroscience·Bettina S FehrTrisha Suppes
Oct 13, 2009·Biological Psychiatry·Ziad NahasIstvan Takacs
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Herbert Y MeltzerJunji Ichikawa
Dec 24, 2003·Journal of Psychiatric Research·Dilip V Jeste, Christian R Dolder
Jan 29, 2002·Lancet·Bruno Müller-OerlinghausenMichael Bauer
Oct 3, 1999·Schizophrenia Research·R M Post
Aug 22, 2002·Journal of Child and Adolescent Psychopharmacology·Gabriele MasiStefania Millepiedi
Jun 1, 2000·Journal of Clinical Psychopharmacology·G E Brannon, P D Rolland
Oct 26, 2000·The Journal of Nervous and Mental Disease·A S Kablinger, A M Freeman
Sep 12, 2009·Journal of Clinical Psychopharmacology·Maneesh Gupta
Jan 6, 2000·The Australian and New Zealand Journal of Psychiatry·P B Mitchell
Jan 10, 2003·Bipolar Disorders·Patricia RussoMauricio Tohen
Jul 24, 2001·Bipolar Disorders·S N Ghaemi
Jul 10, 2014·ISRN Psychiatry·Natalia BartolommeiLorenzo Lattanzi
Jul 15, 1999·Journal of Affective Disorders·C A SoutulloP E Keck
Jun 3, 1998·Journal of Affective Disorders·S L McElroyR M Post
Mar 14, 2016·La Presse médicale·Olivier DoumyEmmanuel Haffen
Apr 25, 2012·Bipolar Disorders·Michael Gitlin, Mark A Frye
Feb 21, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·R M JonesI Bitter
Apr 6, 2004·The Psychiatric Clinics of North America·Elizabeth B WellerRonald A Weller
Jun 5, 2003·Bipolar Disorders·Mukund GnanadesikanAlan J Gelenberg
Oct 28, 2014·Bipolar Disorders·Xian-Bin LiJose de Leon
May 13, 2003·Expert Opinion on Pharmacotherapy·Martin LambertPat D McGorry
Mar 17, 2015·Trends in Pharmacological Sciences·Salomon Z Langer
Nov 23, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·J-M Vanelle, S Douki
Mar 7, 2012·The Australian and New Zealand Journal of Psychiatry·Gin S MalhiMichael Berk
Apr 7, 2009·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Heinz GrunzeSiegfried Kasper
Apr 15, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Kalina Boteva, Jeffrey Lieberman
Sep 4, 1999·Journal of Psychopharmacology·D Zullino, P Baumann
Dec 19, 2001·International Journal of Geriatric Psychiatry·J S KennedyA Breier
Jul 2, 2005·Journal of Psychiatric Practice·S N GhaemiF K Goodwin
Mar 31, 2018·Therapeutic Drug Monitoring·Donatella MarazzitiLiliana DellʼOsso
Feb 28, 2004·FEBS Letters·Ung Gu KangYong Sik Kim
Nov 11, 2006·Current Psychiatry Reports·Prashant GajwaniJoseph R Calabrese
May 10, 2005·Human Psychopharmacology·Eduard Vieta
Jan 25, 2006·Molecular Psychiatry·M Gitlin
May 3, 2002·Molecular Psychiatry·P E KeckM Tohen
Feb 28, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·N GhaemiF K Goodwin

Jan 22, 2020·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Marta H CostaPedro V S Magalhaes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.